Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.15B | 14.54B | 14.66B | 14.85B | 12.52B | 10.58B |
Gross Profit | 4.89B | 5.34B | 5.53B | 5.79B | 5.14B | 4.36B |
EBITDA | 5.64B | 7.07B | 7.34B | 7.39B | 6.65B | 5.76B |
Net Income | 3.10B | 3.47B | 3.71B | 4.17B | 3.78B | 2.77B |
Balance Sheet | ||||||
Total Assets | 42.93B | 42.76B | 42.21B | 41.91B | 40.53B | 39.79B |
Cash, Cash Equivalents and Short-Term Investments | 393.00M | 1.00B | 1.44B | 2.09B | 2.32B | 3.13B |
Total Debt | 19.65B | 18.99B | 19.02B | 18.54B | 16.84B | 17.16B |
Total Liabilities | 30.55B | 30.26B | 30.23B | 29.29B | 27.03B | 26.68B |
Stockholders Equity | 12.38B | 12.50B | 11.98B | 12.63B | 13.50B | 13.11B |
Cash Flow | ||||||
Free Cash Flow | 2.01B | 2.72B | 3.27B | 3.49B | 3.31B | 2.64B |
Operating Cash Flow | 4.96B | 5.25B | 5.55B | 5.62B | 5.10B | 4.26B |
Investing Cash Flow | -3.01B | -2.60B | -2.29B | -2.13B | -1.88B | -649.00M |
Financing Cash Flow | -2.80B | -3.06B | -3.87B | -3.77B | -4.11B | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $130.11B | 19.06 | 42.35% | 2.44% | 1.06% | 8.13% | |
77 Outperform | $62.79B | 18.91 | 24.11% | 1.96% | 0.71% | 86.84% | |
76 Outperform | $66.46B | 21.91 | 24.83% | 1.40% | -3.27% | -10.73% | |
74 Outperform | $52.47B | 12.93 | 14.68% | 2.57% | 0.27% | -2.64% | |
71 Outperform | ¥257.35B | 14.36 | 8.48% | 2.83% | 6.31% | 12.01% | |
67 Neutral | $31.10B | 28.17 | 26.25% | 0.76% | -5.54% | -12.26% | |
67 Neutral | $0.00 | 12.64 | 34.96% | 7.74% | 0.95% | 9.62% |
On May 7, 2025, CSX Corporation held its Annual Meeting of Shareholders where twelve directors were elected to the board. Additionally, shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 and approved, on a non-binding basis, the compensation of CSX’s named executive officers.
The most recent analyst rating on (CSX) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on CSX stock, see the CSX Stock Forecast page.